Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results from the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial

BACKGROUND: Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience excess risk of cardiovascular disease (CVD) and elevated total homocysteine (tHcy) concentrations. Observational studies of patients with CKD suggest increased homocysteine is a risk factor fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circulation
Main Authors: Bostom, Andrew G., Carpenter, Myra A., Kusek, John W., Levey, Andrew S., Hunsicker, Lawrence, Pfeffer, Marc A., Selhub, Jacob, Jacques, Paul F., Cole, Edward, Gravens-Mueller, Lisa, House, Andrew A., Kew, Clifton, McKenney, Joyce L., Pacheco-Silva, Alvaro, Pesavento, Todd, Pirsch, John, Smith, Stephen, Solomon, Scott, Weir, Matthew
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887854/
https://ncbi.nlm.nih.gov/pubmed/21482964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.110.000588
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados